161 related articles for article (PubMed ID: 35717020)
21. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
Andrade ESN; Brandão JG; Silva JSD; Coriolano CRF; Rosa PS; Moraes MO; Ferreira CO; Gomes CM; Araújo WN
Antimicrob Agents Chemother; 2022 May; 66(5):e0217021. PubMed ID: 35435708
[TBL] [Abstract][Full Text] [Related]
22. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
23. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
[TBL] [Abstract][Full Text] [Related]
25. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Cambau E; Perani E; Guillemin I; Jamet P; Ji B
Lancet; 1997 Jan; 349(9045):103-4. PubMed ID: 8996430
[No Abstract] [Full Text] [Related]
26. Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
Cambau E; Bonnafous P; Perani E; Sougakoff W; Ji B; Jarlier V
Clin Infect Dis; 2002 Jan; 34(1):39-45. PubMed ID: 11731943
[TBL] [Abstract][Full Text] [Related]
27. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
28. Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):803-10. PubMed ID: 9656405
[TBL] [Abstract][Full Text] [Related]
29. Case Report: Multidrug-Resistant
Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
[TBL] [Abstract][Full Text] [Related]
30. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
31. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
[TBL] [Abstract][Full Text] [Related]
32. Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug-resistance testing in leprosy?
Narang T; Kamat D; Thakur V; Lavania M; Singh I; Ahuja M; Dogra S
Clin Exp Dermatol; 2022 Feb; 47(2):297-302. PubMed ID: 34382256
[TBL] [Abstract][Full Text] [Related]
33. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
34. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
[TBL] [Abstract][Full Text] [Related]
35. [Drug resistance of multibacillary leprosy patients in Japan--results of molecular genetic analyses].
Ozaki M
Nihon Hansenbyo Gakkai Zasshi; 2008 Sep; 77(3):187-96. PubMed ID: 18800639
[TBL] [Abstract][Full Text] [Related]
36. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
37. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
38. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
39. Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
Cambau E; Chauffour-Nevejans A; Tejmar-Kolar L; Matsuoka M; Jarlier V
PLoS Negl Trop Dis; 2012; 6(7):e1739. PubMed ID: 22860144
[TBL] [Abstract][Full Text] [Related]
40. Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon.
Rosa PS; D'Espindula HRS; Melo ACL; Fontes ANB; Finardi AJ; Belone AFF; Sartori BGC; Pires CAA; Soares CT; Marques FB; Branco FJD; Baptista IMFD; Trino LM; Fachin LRV; Xavier MB; Floriano MC; Ura S; Diório SM; Delanina WFB; Moraes MO; Virmond MCL; Suffys PN; Mira MT
Clin Infect Dis; 2020 May; 70(10):2054-2061. PubMed ID: 31260522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
